Dosage and administration
One tablet three times daily or as directed by a health professional.
One tablet three times daily or as directed by a health professional.
Agnus Castus 6X, 12X, 30X, Ambra Grisea 6X, 12X, 30X, Conium Maculatum 6X, 12X, 30X, Apiolum 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Estradiol 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Estridol 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Folliculinum 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, L-Dopa 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Melatonin 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Testosterone 6X, 12X, 30X, 200X, 12C, 30C, 60C, 200C, Alpha-Lipoicum Acidum 8X, Adenosinum Triphsphoricum Disodium 8X, Coenzyme A 8X, CoQ10 8X, Nadidum 8X, Sarcolacticum Acidum 8X, Baryta Carbonica 8X, 12X, 30X, Selelnium Metallicum 8X, 12X, 30X, Funiculus Umbilicalis Suis 30X, Glandula Suprarenalis Suis 30X, Hepar Suis 30X, Hypothalamus (suis) 30X, Lymph (suis) 30X, Medulla Ossis Suis 30X, Oophorinum (suis) 30X, Orchitinum (suis) 30X, Pancreas Suis 30X, Spleen (suis) 30X, Human Growth Hormone 30X, 60X, 200X, Morgan Pure 30C.
For temporary relief of symptoms related to aging including deterioration of muscles, joints and skin, sexual dysfunction, memory loss and fatigue.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
If pregnant or breast-feeding, ask a health professional before use.
Tamper seal: Sealed for your protection. Do not use if seal is broken or missing.
One tablet three times daily or as directed by a health professional.
Lactose, Magnesium Stearate, Microcrystalline Cellulose.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
For temporary relief of symptoms related to aging including deterioration of muscles, joints and skin, sexual dysfunction, memory loss and fatigue.
Dist. by Deseret Biologicals, Inc.
www.desbio.com
469 Parkland Drive • Sandy, UT 84070
DESBIO
NDC 43742-0022-1
HOMEOPATHIC
HGH
VITALITY
60 TABLETS
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .ALPHA.-LIPOIC ACID | ACTIVE INGREDIENT | 73Y7P0K73Y | 2 | |
| ADENOSINE TRIPHOSPHATE DISODIUM | ACTIVE INGREDIENT | 5L51B4DR1G | 2 | |
| AMBERGRIS | ACTIVE INGREDIENT | XTC0D02P6C | 2 | |
| APIOLE (PARSLEY) | ACTIVE INGREDIENT | QQ67504PXO | 2 | |
| BARIUM CARBONATE | ACTIVE INGREDIENT | 6P669D8HQ8 | 2 | |
| CHASTE TREE | ACTIVE INGREDIENT | 433OSF3U8A | 2 | |
| COENZYME A | ACTIVE INGREDIENT | SAA04E81UX | 2 | |
| CONIUM MACULATUM FLOWERING TOP | ACTIVE INGREDIENT | Q28R5GF371 | 2 | |
| ESTRADIOL | ACTIVE INGREDIENT | 4TI98Z838E | 2 | |
| ESTRIOL | ACTIVE INGREDIENT | FB33469R8E | 2 | |
| ESTRONE | ACTIVE INGREDIENT | 2DI9HA706A | 2 | |
| LACTIC ACID, L- | ACTIVE INGREDIENT | F9S9FFU82N | 2 | |
| LEVODOPA | ACTIVE INGREDIENT | 46627O600J | 2 | |
| MELATONIN | ACTIVE INGREDIENT | JL5DK93RCL | 2 | |
| NADIDE | ACTIVE INGREDIENT | 0U46U6E8UK | 2 | |
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 2 | |
| PROTEUS MORGANII | ACTIVE INGREDIENT | 56X6LID5ZY | 2 | |
| SELENIUM | ACTIVE INGREDIENT | H6241UJ22B | 2 | |
| SOMATROPIN | ACTIVE INGREDIENT | NQX9KB6PCL | 2 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE INGREDIENT | 398IYQ16YV | 2 | |
| SUS SCROFA BONE MARROW | ACTIVE INGREDIENT | VP2CN2G7Y8 | 2 | |
| SUS SCROFA HYPOTHALAMUS | ACTIVE INGREDIENT | N6R0856Z79 | 2 | |
| SUS SCROFA LYMPH | ACTIVE INGREDIENT | 33A7VYU29L | 2 | |
| SUS SCROFA OVARY | ACTIVE INGREDIENT | S7YTV04R8O | 2 | |
| SUS SCROFA PANCREAS | ACTIVE INGREDIENT | 9Y3J3362RY | 2 | |
| SUS SCROFA SPLEEN | ACTIVE INGREDIENT | 92AMN5J79Y | 2 | |
| SUS SCROFA TESTICLE | ACTIVE INGREDIENT | KM02613O28 | 2 | |
| SUS SCROFA UMBILICAL CORD | ACTIVE INGREDIENT | 118OYG6W3H | 2 | |
| TESTOSTERONE | ACTIVE INGREDIENT | 3XMK78S47O | 2 | |
| UBIDECARENONE | ACTIVE INGREDIENT | EJ27X76M46 | 2 | |
| .ALPHA.-LIPOIC ACID | ACTIVE MOIETY | 73Y7P0K73Y | 2 | |
| ADENOSINE TRIPHOSPHATE | ACTIVE MOIETY | 8L70Q75FXE | 2 | |
| AMBERGRIS | ACTIVE MOIETY | XTC0D02P6C | 2 | |
| APIOLE (PARSLEY) | ACTIVE MOIETY | QQ67504PXO | 2 | |
| BARIUM CATION | ACTIVE MOIETY | V645272HLN | 2 | |
| CHASTE TREE | ACTIVE MOIETY | 433OSF3U8A | 2 | |
| COENZYME A | ACTIVE MOIETY | SAA04E81UX | 2 | |
| CONIUM MACULATUM FLOWERING TOP | ACTIVE MOIETY | Q28R5GF371 | 2 | |
| ESTRADIOL | ACTIVE MOIETY | 4TI98Z838E | 2 | |
| ESTRIOL | ACTIVE MOIETY | FB33469R8E | 2 | |
| ESTRONE | ACTIVE MOIETY | 2DI9HA706A | 2 | |
| LACTIC ACID, L- | ACTIVE MOIETY | F9S9FFU82N | 2 | |
| LEVODOPA | ACTIVE MOIETY | 46627O600J | 2 | |
| MELATONIN | ACTIVE MOIETY | JL5DK93RCL | 2 | |
| NADIDE | ACTIVE MOIETY | 0U46U6E8UK | 2 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 2 | |
| PROTEUS MORGANII | ACTIVE MOIETY | 56X6LID5ZY | 2 | |
| SELENIUM | ACTIVE MOIETY | H6241UJ22B | 2 | |
| SOMATROPIN | ACTIVE MOIETY | NQX9KB6PCL | 2 | |
| SUS SCROFA ADRENAL GLAND | ACTIVE MOIETY | 398IYQ16YV | 2 | |
| SUS SCROFA BONE MARROW | ACTIVE MOIETY | VP2CN2G7Y8 | 2 | |
| SUS SCROFA HYPOTHALAMUS | ACTIVE MOIETY | N6R0856Z79 | 2 | |
| SUS SCROFA LYMPH | ACTIVE MOIETY | 33A7VYU29L | 2 | |
| SUS SCROFA OVARY | ACTIVE MOIETY | S7YTV04R8O | 2 | |
| SUS SCROFA PANCREAS | ACTIVE MOIETY | 9Y3J3362RY | 2 | |
| SUS SCROFA SPLEEN | ACTIVE MOIETY | 92AMN5J79Y | 2 | |
| SUS SCROFA TESTICLE | ACTIVE MOIETY | KM02613O28 | 2 | |
| SUS SCROFA UMBILICAL CORD | ACTIVE MOIETY | 118OYG6W3H | 2 | |
| TESTOSTERONE | ACTIVE MOIETY | 3XMK78S47O | 2 | |
| UBIDECARENONE | ACTIVE MOIETY | EJ27X76M46 | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43742-0022 | 43742-0022-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | 4441 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 133 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE / ORAL | 29520 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | 300 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / VAGINAL | 430 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, DELAYED RELEASE / ORAL | 1060 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | 5119 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION / ORAL | 1600 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CREAM / VAGINAL | 3 %w/w | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, SUGAR COATED / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 53 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / BUCCAL | 296.7 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INSERT / VAGINAL | 69 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | FILM, EXTENDED RELEASE / TRANSDERMAL | 675 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / ORAL | 420 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / BUCCAL | 17.5 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION, EXTENDED RELEASE / ORAL | 1120 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 615 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / RECTAL | 20 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INHALANT / ORAL | 0.08 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | 64 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / SUBLINGUAL | 43.2 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6d0a5eec-c85b-47fd-acca-26714ea8911c | c8abebc1-a262-4371-90e9-bf7950b488b9 | 2015-02-04 | Warnings | c8abebc1-a262-4371-90e9-bf7950b488b9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.